Epogen
information and resources from the National Cancer Institute
NCI Thesaurus | Epogen
(Other name for: epoetin alfa)NCI Thesaurus | Epogen
(Other name for: epoetin alfa)
Epoetin alfa
EPOGEN is indicated for the treatment of anemia associated with CRF, including patients on dialysis (ESRD) and patients not on dialysis.
Amgen, Inch Jul 26 1999
Epoetin alfa
EPOGENB is indicated for the reatment of anemia related to therapy with zidovudine in HIV- infected patients. EPOGENB is indicated to elevate or maintain the red blood cell level (as manifested by the hematocrit or hemoglobin determinations) and to decrease the need for transfusions in these patients. EPOGEND is not indicated for the treatment of anemia in HIV-infected patients due to other factors such as iron or folate deficiencies, hemolysis or gastrointestinal bleeding, which should be managed appropriately.
Amgen, Inc Jul 26 1999
Epoetin alfa
EPOGENB is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy. EPOGEND is indicated to decrease the need for transfusions in patients who will be receiving concomitant chemotherapy for a minimum of 2 months. EPOGENB is not indicated for the treatment of anemia in cancer patients due to other factors such as iron or folate deficiencies, hemolysis or gastrointestinal bleeding, which should be managed appropriately.
Amgen, Inc Jul 26 1999
Epoetin alfa
EPOGENB is indicated for the treatment of anemic patients (hemoglobin > 10 to _< 13 g/dL) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions.
Amgen, Inc Jul 26 1999
|
|
|
|
news articles
Bad news for others, good news for Amgen Mar 26, 2006
Ventura County Star (subscription), ...market share. Aranesp, a longer-lasting anemia drug than its predecessor Epogen, has been eating into Epogen's sales as well. But ...
Guilty verdict in AIDS drug scam Mar 28, 2006
Miami Herald, Medications such as Epogen, a drug for kidney dialysis and cancer patients, and Neupogen, used for cancer and HIV patients, were diluted, relabeled and sold to ...
Stada Sees Profit Rising 10% or More on Generics Push (Update4) Mar 30, 2006
Bloomberg The CEO is also making a push into ``biogeneric'' drugs with a copy of Amgen Inc.'s $2.5 billion anemia drug Epogen. Stada, which ...
Rise in phony medication leads to tightened laws Mar 27, 2006
Fort Worth Star Telegram, ...recover from a nine-hour operation that had replaced his liver and left him severely anemic, doctors prescribed a weekly injectable drug called Epogen to boost ...
Man Convicted for Role in South Florida Drug Adulteration Ring, US ... Mar 28, 2006
Lawfuel (press release), ...crime ring included Neupogen, used for cancer and HIV patients; Gammagard (Gamimune, Iveegam and Panglobulin), used for HIV patients; Epogen (Procrit), used ...
Gambro Healthcare - Dialysis Fraud Pays Big Bucks Mar 31, 2006
OpEdNews ...medications and services which were not medically necessary (bone density studies, nerve conduction studies, electrocardiograms, carnitor, epogen, vitamin D ...
Broward Jury Convicts Man of Fraud in Selling Counterfeit ... Mar 28, 2006
International News Service, Martino's company, Optia Medical, doctored paper work to legitimize tens of millions in questionable epogen, Procrit and immune globulin, all expensive ...
Amgen CEO assesses generic threat Mar 1, 2006
MarketWatch ...patents protecting its drug Epogen have already expired in Europe. ... Epogen had sales of $626 million in 2005, while Aranesp took in $873 million. ...
Demand to expand Mar 28, 2006
TMCnet Manufacturing also is being expanded at a cost of $1 billion in Puerto Rico to boost capacity for drugs produced there -- Epogen, Aranesp, Neupogen and Neulasta ...
Aranesp dosed every three weeks achieved and maintained target ... Mar 28, 2006
RxPG NEWS, ...anemia treatment with the development of recombinant erythropoietin, Epoetin alfa, which is currently marketed in the US by Amgen as EPOGEN® (Epoetin alfa)i ...
Biotechs take a stronghold on sales Mar 1, 2006
Newark Star Ledger, Amgen makes four of the top 20 drugs, including Aranesp for kidney-disease-related and chemotherapy-related anemia; Epogen, for anemia from chronic kidney ...
Secret Agents Used in War Against Counterfeit Drugs (Update1) Mar 16, 2006
Bloomberg The measure is named after a liver transplant patient who suffered seizures after being injected with a fake version of Epogen, an anemia treatment made by ...
Amgen will add jobs in Cambridge, CEO says Mar 1, 2006
Boston Herald, ...company is headquartered. Amgen, maker of the anemia drug Epogen, is one of the world’s oldest and largest biotech companies. It has ...
Amgen's "strategic intention" is to acquire - CEO Mar 1, 2006
Reuters ...over. Amgen sued Roche claiming Roche's drug Cera infringes on Amgen's patents for Epogen and its longer-lasting version Aranesp. ...
Where Will You Be Tomorrow? Mar 13, 2006
Motley Fool Amgen (Nasdaq: AMGN) may have won you over with the success of Epogen and Neupogen, but it's the probability of us living longer -- and healthier -- lives that ...
Renal Care Group Announces Fourth Quarter and Year-End Results Mar 9, 2006
Black Enterprise, ...dependence of our profits on the services we provide to a small number of patients who have private insurance; risks related to the drug Epogen (EPO); changes ...
CBS 2 Investigates: Tamiflu Hoarding Hysteria Mar 1, 2006
WCBS-TV New York, ...other fake medicines. Tim Fagan was the victim of a counterfeit medication, Epogen, after a life-saving liver transplant. “I would ...
Amgen to expand research unit here Mar 2, 2006
Boston Globe, Amgen grew from a tiny California start-up in the 1980s on the back of its star drug, Epogen, which treats anemia in cancer patients and patients undergoing ...
The Best-Selling Drugs In America Feb 27, 2006
Forbes According to IMS Health's data, Pfizer makes 3 of the top 20 drugs in the US Amgen makes four of them, including Aranesp, Epogen, Neulasta and Enbrel. ...
Epogen: reports of pure red cell aplasia and severe anemia ... Dec 11, 2005
Xagena.it, Amgen and FDA notified HealthCare Professionals of revision to sections of the prescribing information for Epogen ((Epoetin alfa ). ...
FDA Announcement: Aranesp, Epogen, Procrit Associated with Reports ... Dec 2, 2005
PharmaLive.com (press release), ...letter below. The healthcare letters for Epogen and Procrit are attached along with the revised prescribing labels. Amgen Inc. wishes ...
Zacks.com announces that Richard Moroney highlights the following ... Dec 15, 2005
Business Wire (press release), They manufacture and market four human therapeutic products, EPOGEN(R) (Epoetin alfa), NEUPOGEN(R) (Filgrastim), INFERGEN(R) (Interferon alfacon-1) and STEMGEN ...
Amgen, J&J notify doctors on anemia drugs' disorder Dec 6, 2005
Ventura County Star (subscription), The advice is among changes to the prescribing information for doctors using the three drugs, Aranesp, Epogen and Procrit, the Food and Drug Administration ...
FDA releases warning on Amgen drugs (bizjournals.com) Dec 6, 2005
Financial News USA (press release), Friday December 2, 11:38 am ET The US Food and Drug Administration has issued a warning on Amgen Inc.'s anemia drugs Aransep and Epogen, saying they could ...
Two Companies Issue Warnings on Anemia Drugs Dec 5, 2005
Newsinferno.com, ...about their anemia drugs. Amgen manufactures both Epogen and Aranesp, while Ortho Biotech makes Procrit. The drugs are approved ...
J&J, Amgen Warn Doctors on Anemia Drugs' Disorder (Update1) Dec 1, 2005
Bloomberg 1 (Bloomberg) -- Johnson & Johnson and Amgen Inc.'s anemia drugs Aranesp, Epogen and Procrit may have a risk of damaging red blood cells, known as aplasia, and ...
Alert Issued on Anemia Drugs Dec 2, 2005
Los Angeles Times, Johnson & Johnson and Amgen Inc.'s anemia drugs, Aranesp, Epogen and Procrit, may have a risk of damaging red blood cells in certain patients, US regulators ...
New Medicare Claims Monitoring System for Epoetin, Darbepoetin Use Dec 9, 2005
Medscape (subscription) 9, 2005 — A new Centers for Medicare & Medicaid Services (CMS) policy for monitoring and coverage of erythropoietin (EPO; Epogen) or darbepoetin alfa (Aranesp ...
FDA releases warning on Amgen drugs Dec 2, 2005
Bizjournals.com, The US Food and Drug Administration has issued a warning on Amgen Inc.'s anemia drugs Aransep and Epogen, saying they could cause a blood condition known as ...
Former pharmacy owner sent to prison Dec 10, 2005
The Journal News.com, ...claim forms, Spitzer's office said. The medications included anemia drugs Procrit and Epogen. They also included Neupogen, which ...
Rx drug law puts Florida at forefront Nov 28, 2005
Orlando Business Journal, And yet, those are the patients most likely to end up buying counterfeit drugs, because their pricey medications such as Epogen and Procrit are among the most ...
Higher doses of pegylated interferon or ribavirin improve ... Dec 8, 2005
Aidsmap, Mitchell Shiffman presented data from a study in which erythropoietin (EPO, brand names Procrit, Eprex, Epogen), a hormone that stimulates red blood cell ...
Roche anaemia drugs may have cheaper rivals soon Dec 7, 2005
Financial Express, ...be clear for them to take off,� said George Morrow, executive vice-president of commercial operations at Amgen Inc, which sells the Epogen anemia treatment ...
Fresenius Medical Care Subsidiary Commences Cash Tender Offer for ... Nov 30, 2005
Business Wire (press release), ...in the Medicare and Medicaid; changes in the health care delivery, financing or reimbursement systems; risks related to the drug Epogen (EPO); compliance with ...
National Briefs Dec 2, 2005
New York Times, Their manufacturers, Johnson & Johnson and Amgen, have notified doctors that the drugs - Aranesp, Epogen and Procrit - should be discontinued if patients ...
A test of life: Runner rebuilding life in Oro Valley while ... Nov 23, 2005
Northwest Explorer, It's also believed to help reduce rejection rates in transplant patients. Common doctor-prescribed forms of the drug are Epogen and Procrit. ...
Counterfeiters extend beyond biggest drugs Nov 19, 2005
Newark Star Ledger, Kidney-transplant patient Tim Fagan nearly died after taking counterfeit Epogen -- a pill that stimulates the production of red blood cells -- that he ...
|
|
